AbbVie (ABBV)
$159.62
7.67 (4.58%)
ABBV Stock Quote Delayed 30 Minutes
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
7.38M
Day's Range
$157.65 - $167.46
52-Week Range
$130.96 - $182.89
Dividend & Yield
$5.92 (3.71%)
ABBV Stock Predictions, Articles, and AbbVie News
Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year
These seven dividend stocks provide a base for $50,000 in income per year for dedicated investors with patience.
Why Is Landos Biopharma (LABP) Stock Up 168% Today?
Landos Biopharma stock is up on Monday as LABP investors learn about a massive acquisition deal with AbbVie that values it at $137.5 million.
3 Must-Have Dividend Kings for a Steady Income Stream
Discover the dividend kings with constant growth, dominating pharmaceuticals, household products and biotechnology industries.
Blue-Chip Backbone: 3 Stocks for Unwavering Market Strength
With many shiny objects to distract you, it takes patience to ride your blue-chip stocks higher, but these three stocks continue to deliver.
